Τόμος 29 (2015) – Τεύχος 2 – Άρθρο 3 – Review of Clinical Pharmacology and Pharmacokinetics- Διεθνής Έκδοση – Volume 29 (2015) – Issue 2 – Article 3 – Review of Clinical Pharmacology and Pharmacokinetics – International Edition

By | | Αικατερίνη Τσίπουρα - Aikaterini Tsipoura, Άρθρο - Article, Γεώργιος Ιατράκης - G. M. Iatrakis, Ελευθερία Ψαρράκη - Eleftheria Psarraki, Μαρία Χρονοπούλου - Maria Chronopoulou, Πλήρες Κείμενο στα Αγγλικά - Full Text in English, Στέφανος Ζερβούδης - Stefanos Zervoudis

 

Τίτλος – Title
Association of human papillomavirus infection with
chlamydia trachomatis and ureaplasma urealyticum infections in women
Συγγραφέας – Author

1Ελευθερία Ψαρράκη, 1Αικατερίνη Τσίπουρα, 1Μαρία Χρονοπούλου, 1,2Στέφανος Ζερβούδης, 1,2Γεώργιος Ιατράκης
1Τ.Ε.Ι. Αθήνας, Αιγάλεω,  2Μαιυτήριο Ρέα,  Αθήνα, Ελλάς –
Psarraki Eleftheria1, Tsipoura Aikaterini1 , Chronopoulou Maria1, Zervoudis Stefanos1,2, Iatrakis Georgios1,2
1Technological Educational Institute (TEI) of Athens, 2Rea Maternity Hospital, Athens, Greece
Παραπομπή – Citation
Psarraki E., Tsipoura A. , Chronopoulou M., Zervoudis S., Iatrakis G.: Association of human papillomavirus infection with chlamydia trachomatis and ureaplasma urealyticum infections in women, Review Clin. Pharmakol. Pharmakokinet. 29: 103-104 (2015)
Ημερομηνία Δημοσιευσης – Publication Date
01 Ιουλίου 2015 – 2015-07-01
Γλώσσα Πλήρους Κειμένου –
Full Text Language

Αγγλικά – English
Λέξεις κλειδιά – Keywords
Χλαμύδια, καρκίνος του τραχήλου της μήτρας –
human papillomavirus (HPV), chlamydia trachomatis (CT), ureaplasma urealyticum (UU), cervinal cancer, Cobas 4800 HPV Test
Λοιποί Όροι – Other Terms

άρθρο  –
article

 

Περίληψη – Summary

 
The objective of the present study is to verify possible association between human papillomavirus (HPV) infection with chlamydia trachomatis (CT) and ureaplasma urealyticum (UU) infections in women. It is an association which has drawn attention to a great proportion of health professionals around the world. According to many studies, such as the ones referenced below, this association is actually confirmed and for this reason it could be suggested a wider evaluation of co-infections in women who have high risk for premalignantcervical lesions.
Αναφορές – References
 1. Nosayaba Osazuwa-Peters, Dawei DW, Namin A, Vivek MJ, O’Neill M, Pranav V. Patel, Varvares MA. Sexual behavior, HPV knowledge, and association with head and neck cancer among a high-risk group. Oral Oncology 51 (2015) 452–456.
2. Biernat-Sudolska M, Szostek S, Rojek-Zakrzewska D, Klimek M, Kosz-Vnenchak M. Concomitant infections with human papillomavirus and various mycoplasma and ureaplasma species in women with abnormal cervical cytology. Adv Med Sci 2011; 56:299-303.
3. Zheng MY, Zhao HL, Di JP, Lin G, Lin Y, Lin X, Zheng MQ. Association of human papillomavirus infection with other microbial pathogens in gynecology. Adv Zhonghua fu Chan ke za zhi 2010; 45:424-8.
4. Tavares MC, de Macêdo JL, de Lima Júnior SF, de Andrade Heráclio S, Amorim MM, de Mascena Diniz Maia M, de Souza PR. Chlamydia trachomatis infection and human papillomavirus in women with cervical neoplasia in Pernambuco-Brazil. Adv Molecular Biology Reports 2014; 41:865-74.
5. Castellsagué X, Pawlita M, Roura E, Margall N, Waterboer T, Bosch FX, de Sanjosé S, Gonzalez CA, Dillner J, Gram IT, Tjønneland A, Munk C, Pala V, Palli D,Khaw KT, Barnabas RV, Overvad K, Clavel-Chapelon F, Boutron-Ruault MC, Fagherazzi G, Kaaks R, Lukanova A, Steffen A, Trichopoulou A, Trichopoulos D, Klinaki E, Tumino R, Sacerdote C, Mattiello A, Bueno-de-Mesquita HB, Peeters PH, Lund E, Weiderpass E, Quirós JR, Sánchez MJ, Navarro C, Barricarte A, Larrañaga N, Ekström J, Hortlund M, Lindquist D, Wareham N, Travis RC, Rinaldi S, Tommasino M, Franceschi S, Riboli E. Prospective seroepidemiologic study on the role of Human Papillomavirus and other infections in cervical carcinogenesis: evidence from the EPIC cohort. Adv International Journal of Cancer 2014;
135:440–452.
6. Iatrakis G. Chlamydia trachomatis infection. In:  Gynecologic Oncology. Athens, Desmos Publications 2013.
7. Luostarinen T, Namujju PB, Merikukka M, Dillner J,  Hakulinen T, Koskela P, Paavonen J, Surcel HM, Lehtinen M. Order of HPV/Chlamydia infections and cervical high-grade precancer risk: A case-cohort study. Int J Cancer 2013, doi: 10.1002/ijc.28173.
8. Mendoza L, Mongelos P, Paez M, Castro A, Rodriguez-Riveros I, Gimenez G, Araujo P, Echagüe G, Diaz V, Laspina F, Castro W, Jimenez R, Marecos R, Ever S, Deluca G, Picconi MA. Human papillomavirus and other genital infections in indigenous women from Paraguay: a cross-sectional analytical study. BMC Infect Dis 2013; 13:531.
9. Bellaminutti S, Seraceni S, De Seta F, Gheit T, Tommasino M, Comar M. HPV and Chlamydia trachomatis codetection in young asymptomatic women from high incidence area for cervical cancer. Journal of Medical Virology 2014; 86:1920–5.
10. Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 2015;64(RR-03):1-137.
11. Stoler MH, Wright Jr TC, Sharma A, Apple R, Gutekunst K,Wright TL. High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV Study. Am J Clin Pathol. 2011; 135:468–75.15.
12. Parra-Sánchez M, Palomares JC, Bernal S, González MT, Sivianes N, Pérez L, Pueyo I, Martín-Mazuelos E. Evaluation of the cobas 4800 CT/NG Test for detecting Chlamydia trachomatis and Neisseria gonorrhoeae DNA in urogenital swabs and urine specimens. Diagnostic Microbiology and Infectious Disease 74 (2012) 338–342.
13. Bernal S, Palomares JC, Artura A, Parra M, Cabezas JL, Robles A, Martín- Mazuelos E. Comparison of urine and cervical samples for detecting human papillomavirus (HPV) with the Cobas 4800 HPV test. Journal of Clinical Virology 61 (2014) 548–552.
Σχετικές Εργασίες – Relative Papers

Online ISSN 1011-6575

Bookmark the permalink.

Comments are closed.